- Wealth
- ₹2,400 Cr
- Company
- Sms Pharmaceuticals
About Ramesh Babu Potluri
Data last updated:
Ramesh Babu Potluri is a Managing Director at Sms Pharmaceuticals Limited (since 2008), Additional Director at Satyadivis Pharmaceuticals Private Limited (since 2025) and Director at Vkt Pharma Private Limited (since 2006), and holds 3 more current directorships. The companies operate in Pharma, Paper and Research and Development. The 3 current companies with reported revenue have a combined latest revenue of ₹888 Cr; the largest is Sms Pharmaceuticals Limited at ₹789 Cr (FY 2025). Earlier, Ramesh Babu Potluri was a Director at Yeswanth Industrial Infrastruture Projects Private Limited (U/S 21) (2008–2013) and Director at Pharmaceuticals Export Promotion Council Of India (2018–2021) and 3 more.
Ramesh Babu Potluri and family are #1,090 among India's richest people (2026), with wealth of ₹2,400 Cr.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Dec 2008 | 1987 | ₹789 Cr (FY 2025) | Active | |
| Additional Director | 19 Dec 2025 | 1992 | ₹67.35 Cr (FY 2024) | Active | |
| Director | 31 May 2006 | 2006 | ₹31.93 Cr (FY 2023) | Active | |
| Director | 01 Nov 2024 | 2024 | Active | ||
| Designated Partner | 27 Jun 2023 | 2023 | Active | ||
| Partner | 13 Mar 2023 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Mar 2008 | 2004 | Active | ||
| Director | 25 Apr 2018 | 2004 | ₹35.95 Cr (FY 2024) | Active | |
| Director | 02 Aug 2018 | 2012 | ₹35.66 Cr (FY 2023) | Active | |
| Director | 01 Apr 2016 | 2006 | ₹350 Cr (FY 2025) | Active | |
| Director | 31 Jul 1998 | 1998 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramesh Babu Potluri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Babu Potluri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Babu Potluri
Ramesh Babu Potluri currently holds 6 directorships: Sms Pharmaceuticals Limited (Managing Director, since 01 Dec 2008, revenue ₹789 Cr (FY 2025)); Satyadivis Pharmaceuticals Private Limited (Additional Director, since 19 Dec 2025, revenue ₹67.35 Cr (FY 2024)); Vkt Pharma Private Limited (Director, since 31 May 2006, revenue ₹31.93 Cr (FY 2023)); Sms Peptides Private Limited (Director, since 01 Nov 2024); Potluri Agri Farms Llp (Designated Partner, since 27 Jun 2023); and 1 more.
Ramesh Babu Potluri was first appointed on 31 Jul 1998 as Director at Webcity Pharmatech Private Limited. The most recent appointment on record is 19 Dec 2025 at Satyadivis Pharmaceuticals Private Limited.
The 3 current companies of Ramesh Babu Potluri that report revenue have a combined latest revenue of ₹888 Cr: Sms Pharmaceuticals Limited ₹789 Cr (FY 2025); Satyadivis Pharmaceuticals Private Limited ₹67.35 Cr (FY 2024); Vkt Pharma Private Limited ₹31.93 Cr (FY 2023).
Ramesh Babu Potluri held 5 earlier board appointments: Yeswanth Industrial Infrastruture Projects Private Limited (U/S 21) (Director, 15 Mar 2008 to 07 Nov 2013); Pharmaceuticals Export Promotion Council Of India (Director, 25 Apr 2018 to 18 Jan 2021); Mahi Drugs Private Limited (Director, 02 Aug 2018 to 18 Jun 2021); Haleos Labs Limited (Director, 01 Apr 2016 to 18 Jun 2021); Webcity Pharmatech Private Limited (Director, from 31 Jul 1998).
The current boards of Ramesh Babu Potluri's companies include Lakshmi Narayana Tammineedi (Sms Pharmaceuticals Limited), Shanti Sree Bolleni (Sms Pharmaceuticals Limited), Shravan Kudaravalli (Sms Pharmaceuticals Limited), Srinivas Sarvepalli (Sms Pharmaceuticals Limited), Sunkara Venkata Satya Shiva Prasad (Sms Pharmaceuticals Limited), Suresh Kumar Gangavarapu (Sms Pharmaceuticals Limited), among others.